- Home
- CVLG vs AVTX Comparison
CVLG vs AVTX Comparison
Compare CVLG & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVLG | AVTX |
|---|---|---|
| Founded | 1986 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 956.7M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CVLG | AVTX |
|---|---|---|
| Price | $45.50 | $19.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $40.57 |
| AVG Volume (30 Days) | 168.9K | ★ 2.0M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $705,007,000.00 | $27,813,137.00 |
| Revenue This Year | $7.17 | N/A |
| Revenue Next Year | $7.53 | N/A |
| P/E Ratio | $259.71 | ★ N/A |
| Revenue Growth | 5.12 | ★ 2312.27 |
| 52 Week Low | $18.00 | $4.73 |
| 52 Week High | $47.08 | $24.27 |
Technical Indicators
Market Signals| Indicator | CVLG | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.24 | 60.64 |
| Support Level | $42.00 | $13.13 |
| Resistance Level | $47.08 | $20.72 |
| Average True Range (ATR) | 1.54 | 1.45 |
| MACD | -0.30 | 0.30 |
| Stochastic Oscillator | 84.32 | 75.71 |
Price Performance
Historical ComparisonAbout CVLG Covenant Logistics Group Inc.
Covenant Logistics Group Inc together with its wholly-owned subsidiaries, offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight, and Warehousing. The expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. The Managed Freight segment includes brokerage services and TMS. The warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.